These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


210 related items for PubMed ID: 25402174

  • 1. Mouse models of aerosol-acquired tularemia caused by Francisella tularensis types A and B.
    Fritz DL, England MJ, Miller L, Waag DM.
    Comp Med; 2014 Oct; 64(5):341-50. PubMed ID: 25402174
    [Abstract] [Full Text] [Related]

  • 2. Experimental tularemia in mice challenged by aerosol or intradermally with virulent strains of Francisella tularensis: bacteriologic and histopathologic studies.
    Conlan JW, Chen W, Shen H, Webb A, KuoLee R.
    Microb Pathog; 2003 May; 34(5):239-48. PubMed ID: 12732472
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Virulence comparison in mice of distinct isolates of type A Francisella tularensis.
    Twine SM, Shen H, Kelly JF, Chen W, Sjöstedt A, Conlan JW.
    Microb Pathog; 2006 Mar; 40(3):133-8. PubMed ID: 16448801
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
    Wayne Conlan J, Shen H, Kuolee R, Zhao X, Chen W.
    Vaccine; 2005 Mar 31; 23(19):2477-85. PubMed ID: 15752834
    [Abstract] [Full Text] [Related]

  • 12. The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Francisella tularensis SCHU S4 Infection in BALB/c Mice and Cynomolgus Macaques.
    Grossman TH, Anderson MS, Christ D, Gooldy M, Henning LN, Heine HS, Kindt MV, Lin W, Siefkas-Patterson K, Radcliff AK, Tam VH, Sutcliffe JA.
    Antimicrob Agents Chemother; 2017 Aug 31; 61(8):. PubMed ID: 28559261
    [Abstract] [Full Text] [Related]

  • 13. Experimental murine tularemia caused by Francisella tularensis, live vaccine strain: a model of acquired cellular resistance.
    Anthony LS, Kongshavn PA.
    Microb Pathog; 1987 Jan 31; 2(1):3-14. PubMed ID: 3507552
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A.
    Wu TH, Hutt JA, Garrison KA, Berliba LS, Zhou Y, Lyons CR.
    Infect Immun; 2005 May 31; 73(5):2644-54. PubMed ID: 15845466
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112.
    Hall JD, Woolard MD, Gunn BM, Craven RR, Taft-Benz S, Frelinger JA, Kawula TH.
    Infect Immun; 2008 Dec 31; 76(12):5843-52. PubMed ID: 18852251
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.